Date:3/15/2012

cast will also be available through CPHI's website at http://www.chinapharmaholdings.com.  A replay of the call will be accessible through March 22, 2012 by dialing 1-866-214-5335 or 61-282-355-000 for international callers, Conference ID # 59409919.

About China Pharma Holdings, Inc. China Pharma Holdings, Inc. is a rapidly growing specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high-margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com.

Safe Harbor Statement Certain statements in this press release constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as the achievability of financial guidance, success of new product development, unanticipated changes in product demand, increased competition, downturns in the Chinese economy, uncompetitive levels of research and development, and other informatio
'/>"/>

SOURCE China Pharma Holdings, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine technology :

1. Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
2. QIAGEN Expands Access to State-of-the-art HPV Screening in China Through Co-marketing Agreement With KingMed Diagnostics
3. EntreMed Initiates Plans for China Office
4. China Kanghui Holdings to Report Fourth Quarter and Full Year 2011 Financial Results
5. Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China
6. Access Pharmaceuticals Receives Final Marketing Approval From SFDA of China for MuGard
7. Boston Scientific Announces First Implants of TELIGEN® Implantable Defibrillator in China
8. The Prostate Cancer Foundation Builds Momentum in China
9. China Laboratory and Medical Sterilization Equipment and Apparatus Manufacturing Industry, 2012
10. China Sky One Medical Reiterates CEO Sick Leave and Announces Significant Middle Management Resignations
11. 3SBio Inc. to Present at the Oppenheimer & Co. 6th Annual China Dragon Conference